nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—Hallucination, visual—Cyclosporine—focal segmental glomerulosclerosis	0.156	0.182	CcSEcCtD
Scopolamine—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.0471	0.0548	CcSEcCtD
Scopolamine—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.0331	0.0385	CcSEcCtD
Scopolamine—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.0329	0.0384	CcSEcCtD
Scopolamine—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.0271	0.0316	CcSEcCtD
Scopolamine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0261	0.0304	CcSEcCtD
Scopolamine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.0256	0.0298	CcSEcCtD
Scopolamine—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.0239	0.0279	CcSEcCtD
Scopolamine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0222	0.0258	CcSEcCtD
Scopolamine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.0203	0.0237	CcSEcCtD
Scopolamine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0202	0.0236	CcSEcCtD
Scopolamine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0201	0.0234	CcSEcCtD
Scopolamine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0197	0.023	CcSEcCtD
Scopolamine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.019	0.0221	CcSEcCtD
Scopolamine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.0183	0.0213	CcSEcCtD
Scopolamine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0179	0.0209	CcSEcCtD
Scopolamine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.0168	0.0196	CcSEcCtD
Scopolamine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.0167	0.0195	CcSEcCtD
Scopolamine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.0164	0.0191	CcSEcCtD
Scopolamine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.016	0.0187	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.0151	0.0176	CcSEcCtD
Scopolamine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.0148	0.0173	CcSEcCtD
Scopolamine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.0147	0.0171	CcSEcCtD
Scopolamine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.0145	0.0169	CcSEcCtD
Scopolamine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0143	0.0166	CcSEcCtD
Scopolamine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0141	0.0165	CcSEcCtD
Scopolamine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.0141	0.0164	CcSEcCtD
Scopolamine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.0129	0.0151	CcSEcCtD
Scopolamine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0146	CcSEcCtD
Scopolamine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.0124	0.0145	CcSEcCtD
Scopolamine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.0124	0.0145	CcSEcCtD
Scopolamine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.014	CcSEcCtD
Scopolamine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0134	CcSEcCtD
Scopolamine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0134	CcSEcCtD
Scopolamine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0122	CcSEcCtD
Scopolamine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.012	CcSEcCtD
Scopolamine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00962	0.0112	CcSEcCtD
Scopolamine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00925	0.0108	CcSEcCtD
Scopolamine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00917	0.0107	CcSEcCtD
Scopolamine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00916	0.0107	CcSEcCtD
Scopolamine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00911	0.0106	CcSEcCtD
Scopolamine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00864	0.0101	CcSEcCtD
Scopolamine—CHRM3—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.00103	0.00726	CbGpPWpGaD
Scopolamine—CHRM2—Calcium Regulation in the Cardiac Cell—GNAQ—focal segmental glomerulosclerosis	0.00102	0.00721	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00101	0.00711	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.001	0.00707	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	0.000996	0.00702	CbGpPWpGaD
Scopolamine—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000975	0.00687	CbGpPWpGaD
Scopolamine—SI—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000972	0.00684	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000967	0.00681	CbGpPWpGaD
Scopolamine—CHRM5—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.000952	0.0067	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.000925	0.00651	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.000922	0.00649	CbGpPWpGaD
Scopolamine—CHRM4—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.000914	0.00644	CbGpPWpGaD
Scopolamine—CHRM4—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000907	0.00638	CbGpPWpGaD
Scopolamine—CHRM5—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.000876	0.00617	CbGpPWpGaD
Scopolamine—SI—Disease—LPL—focal segmental glomerulosclerosis	0.000873	0.00615	CbGpPWpGaD
Scopolamine—CHRM5—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000868	0.00611	CbGpPWpGaD
Scopolamine—CHRM1—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.000865	0.00609	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.000862	0.00607	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.000852	0.006	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.000846	0.00595	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	0.000835	0.00588	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.000816	0.00575	CbGpPWpGaD
Scopolamine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000795	0.0056	CbGpPWpGaD
Scopolamine—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000792	0.00558	CbGpPWpGaD
Scopolamine—CHRM1—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.000791	0.00557	CbGpPWpGaD
Scopolamine—CHRM5—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00079	0.00556	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.000788	0.00555	CbGpPWpGaD
Scopolamine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000785	0.00552	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000777	0.00547	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.000773	0.00544	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.000771	0.00543	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000769	0.00542	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000744	0.00524	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000744	0.00524	CbGpPWpGaD
Scopolamine—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000739	0.00521	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000737	0.00519	CbGpPWpGaD
Scopolamine—SI—Metabolism—LPL—focal segmental glomerulosclerosis	0.000731	0.00515	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.000707	0.00498	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000707	0.00498	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.000705	0.00496	CbGpPWpGaD
Scopolamine—CHRM4—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000687	0.00484	CbGpPWpGaD
Scopolamine—SI—Disease—NOS2—focal segmental glomerulosclerosis	0.000682	0.0048	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000681	0.0048	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000679	0.00478	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000672	0.00473	CbGpPWpGaD
Scopolamine—CHRM1—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00067	0.00472	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.000668	0.00471	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000658	0.00464	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000631	0.00444	CbGpPWpGaD
Scopolamine—SI—Metabolism—AGT—focal segmental glomerulosclerosis	0.000626	0.0044	CbGpPWpGaD
Scopolamine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000623	0.00438	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.000617	0.00434	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.000615	0.00433	CbGpPWpGaD
Scopolamine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000611	0.0043	CbGpPWpGaD
Scopolamine—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000609	0.00429	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.000609	0.00429	CbGpPWpGaD
Scopolamine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000603	0.00425	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.0006	0.00422	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.000598	0.00421	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000591	0.00416	CbGpPWpGaD
Scopolamine—SI—Disease—SERPINE1—focal segmental glomerulosclerosis	0.000574	0.00404	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000566	0.00399	CbGpPWpGaD
Scopolamine—CHRM1—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.000556	0.00392	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.000555	0.00391	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000547	0.00385	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000524	0.00369	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000523	0.00369	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000522	0.00368	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000519	0.00365	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000517	0.00364	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000517	0.00364	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000512	0.0036	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000501	0.00353	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000498	0.0035	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000496	0.00349	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00048	0.00338	CbGpPWpGaD
Scopolamine—SI—Metabolism—ALB—focal segmental glomerulosclerosis	0.00048	0.00338	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.00048	0.00338	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000458	0.00322	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000444	0.00313	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000443	0.00312	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000438	0.00309	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000437	0.00308	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000435	0.00306	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000419	0.00295	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000416	0.00293	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000416	0.00293	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000411	0.00289	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.000404	0.00284	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000399	0.00281	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000399	0.00281	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000398	0.0028	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000397	0.0028	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000395	0.00278	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000394	0.00277	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000393	0.00277	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00038	0.00268	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000378	0.00266	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000377	0.00266	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000376	0.00265	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000369	0.00259	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000367	0.00259	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000365	0.00257	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000364	0.00256	CbGpPWpGaD
Scopolamine—SI—Disease—TGFB1—focal segmental glomerulosclerosis	0.000363	0.00255	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000361	0.00254	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00035	0.00246	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	0.00034	0.0024	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000338	0.00238	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000337	0.00237	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000334	0.00235	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000334	0.00235	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000332	0.00234	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00032	0.00225	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000319	0.00225	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000318	0.00224	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000305	0.00215	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000304	0.00214	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000295	0.00208	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000294	0.00207	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000293	0.00206	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000292	0.00206	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000291	0.00205	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000291	0.00205	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000289	0.00204	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000283	0.002	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000281	0.00198	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00028	0.00197	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000277	0.00195	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000277	0.00195	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000276	0.00194	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000273	0.00192	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000271	0.00191	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000268	0.00188	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000267	0.00188	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000266	0.00187	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000265	0.00187	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000264	0.00186	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000263	0.00185	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000257	0.00181	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000255	0.0018	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000254	0.00179	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000254	0.00179	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000251	0.00177	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000246	0.00173	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000246	0.00173	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000246	0.00173	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000243	0.00171	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000235	0.00166	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000235	0.00165	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000233	0.00164	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000225	0.00159	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000225	0.00159	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000225	0.00158	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000225	0.00158	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000224	0.00158	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000223	0.00157	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000223	0.00157	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000222	0.00157	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000221	0.00156	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000215	0.00151	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000214	0.00151	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000214	0.0015	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000212	0.00149	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000205	0.00144	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000205	0.00144	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000204	0.00144	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000202	0.00142	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000196	0.00138	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000194	0.00137	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000191	0.00135	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00019	0.00134	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000189	0.00133	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000188	0.00132	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000179	0.00126	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000174	0.00122	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000173	0.00122	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000172	0.00121	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000171	0.00121	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000171	0.0012	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000168	0.00118	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000159	0.00112	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000158	0.00111	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000158	0.00111	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000158	0.00111	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000158	0.00111	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000157	0.00111	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000157	0.0011	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000157	0.0011	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000156	0.0011	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000155	0.00109	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000152	0.00107	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000147	0.00104	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000146	0.00102	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000144	0.00101	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000144	0.00101	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000142	0.001	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000141	0.000994	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00014	0.000984	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000134	0.000942	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000132	0.000931	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000132	0.000928	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00013	0.000919	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000126	0.000888	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000123	0.000868	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000121	0.000851	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000121	0.000851	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000121	0.000849	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000119	0.00084	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—LPL—focal segmental glomerulosclerosis	0.000119	0.000835	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000117	0.000821	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000112	0.000786	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000109	0.000764	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000105	0.000742	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000102	0.000722	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000102	0.000719	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AGT—focal segmental glomerulosclerosis	0.000101	0.000714	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000101	0.000712	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.0001	0.000704	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.94e-05	0.0007	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.91e-05	0.000698	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.82e-05	0.000691	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.7e-05	0.000683	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.42e-05	0.000663	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.39e-05	0.000661	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.3e-05	0.000655	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.29e-05	0.000654	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.51e-05	0.000599	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.48e-05	0.000597	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.4e-05	0.000591	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.86e-05	0.000553	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.84e-05	0.000552	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ALB—focal segmental glomerulosclerosis	7.78e-05	0.000548	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.76e-05	0.000546	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	7.52e-05	0.00053	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.43e-05	0.000523	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.12e-05	0.000501	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.54e-05	0.000461	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.52e-05	0.000459	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.46e-05	0.000455	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	6.44e-05	0.000453	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.12e-05	0.000431	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.86e-05	0.000413	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.01e-05	0.000353	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.99e-05	0.000352	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.95e-05	0.000348	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	4.94e-05	0.000348	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.13e-05	0.000291	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.12e-05	0.00029	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.08e-05	0.000287	CbGpPWpGaD
